|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1989-5-5
|
|
pubmed:abstractText |
To determine whether trisodium phosphonoformate (foscarnet) is efficacious in treating severe mucocutaneous disease due to acyclovir-resistant herpes simplex virus type-2 (HSV-2) infection in patients with the acquired immunodeficiency syndrome (AIDS).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
710-3
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:2522751-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:2522751-Acyclovir,
pubmed-meshheading:2522751-Adult,
pubmed-meshheading:2522751-Antiviral Agents,
pubmed-meshheading:2522751-Drug Resistance, Microbial,
pubmed-meshheading:2522751-Foscarnet,
pubmed-meshheading:2522751-Herpes Simplex,
pubmed-meshheading:2522751-Humans,
pubmed-meshheading:2522751-Infusions, Intravenous,
pubmed-meshheading:2522751-Male,
pubmed-meshheading:2522751-Microbial Sensitivity Tests,
pubmed-meshheading:2522751-Organophosphorus Compounds,
pubmed-meshheading:2522751-Phosphonoacetic Acid
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
|
|
pubmed:affiliation |
University of California, San Francisco.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports
|
